These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 22368385)
1. Metabolic pathway analysis and molecular docking analysis for identification of putative drug targets in Toxoplasma gondii: novel approach. Gautam B; Singh G; Wadhwa G; Farmer R; Singh S; Singh AK; Jain PA; Yadav PK Bioinformation; 2012; 8(3):134-41. PubMed ID: 22368385 [TBL] [Abstract][Full Text] [Related]
2. Selective host autophagy is induced during the intracellular parasite White MD; Angara RK; Dias LT; Shinde DD; Thomas VC; Augusto L mSphere; 2024 Jul; ():e0036924. PubMed ID: 38980070 [TBL] [Abstract][Full Text] [Related]
3. Profiling of myristoylation in Broncel M; Dominicus C; Vigetti L; Nofal SD; Bartlett EJ; Touquet B; Hunt A; Wallbank BA; Federico S; Matthews S; Young JC; Tate EW; Tardieux I; Treeck M Elife; 2020 Jul; 9():. PubMed ID: 32618271 [TBL] [Abstract][Full Text] [Related]
4. Host autophagy is exploited by the intracellular parasite White MD; Angara RK; Dias LT; Shinde DD; Thomas VC; Augusto L bioRxiv; 2023 Dec; ():. PubMed ID: 38106117 [TBL] [Abstract][Full Text] [Related]
5. Targeting Heat Shock Proteins 60 and 70 of Toxoplasma gondii as a Potential Drug Target: In Silico Approach. Ashwinder K; Kho MT; Chee PM; Lim WZ; Yap IK; Choi SB; Yam WK Interdiscip Sci; 2016 Dec; 8(4):374-387. PubMed ID: 26297309 [TBL] [Abstract][Full Text] [Related]
13. Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination. Jensen KD; Camejo A; Melo MB; Cordeiro C; Julien L; Grotenbreg GM; Frickel EM; Ploegh HL; Young L; Saeij JP mBio; 2015 Feb; 6(2):e02280. PubMed ID: 25714710 [TBL] [Abstract][Full Text] [Related]
14. Transcriptomic analysis of mouse liver reveals a potential hepato-enteric pathogenic mechanism in acute Toxoplasma gondii infection. He JJ; Ma J; Elsheikha HM; Song HQ; Huang SY; Zhu XQ Parasit Vectors; 2016 Aug; 9(1):427. PubMed ID: 27488578 [TBL] [Abstract][Full Text] [Related]
15. Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis. Ferrarini MG; Nisimura LM; Girard RMBM; Alencar MB; Fragoso MSI; Araújo-Silva CA; Veiga AA; Abud APR; Nardelli SC; Vommaro RC; Silber AM; France-Sagot M; Ávila AR mSphere; 2021 Jan; 6(1):. PubMed ID: 33408226 [TBL] [Abstract][Full Text] [Related]
16. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis. Anishetty S; Pulimi M; Pennathur G Comput Biol Chem; 2005 Oct; 29(5):368-78. PubMed ID: 16213791 [TBL] [Abstract][Full Text] [Related]
17. Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells. Dzitko K; Grzybowski MM; Pawełczyk J; Dziadek B; Gatkowska J; Stączek P; Długońska H Parasit Vectors; 2015 Aug; 8():422. PubMed ID: 26272689 [TBL] [Abstract][Full Text] [Related]
18. Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18. Molina D; Cossio-Pérez R; Rocha-Roa C; Pedraza L; Cortes E; Hernández A; Gómez-Marín JE BMC Genomics; 2018 Nov; 19(1):856. PubMed ID: 30497375 [TBL] [Abstract][Full Text] [Related]
19. Transcriptomic profiling of long non-coding RNAs and messenger RNAs in the liver of mice during Toxoplasma gondii infection. Zou Y; Yang X; Chen C; Ma H; Cao HW; Jiang J; Wei XY; Zhang XX Parasit Vectors; 2024 Jan; 17(1):20. PubMed ID: 38229193 [TBL] [Abstract][Full Text] [Related]
20. The pathogenicity and virulence of Sanchez SG; Besteiro S Virulence; 2021 Dec; 12(1):3095-3114. PubMed ID: 34895084 [No Abstract] [Full Text] [Related] [Next] [New Search]